I am experiencing next‑day drowsiness, dizziness, and anxiety from mirtazapine, and it is not improving my sleep—should I discontinue it and what alternatives can I use for insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Discontinue Mirtazapine and Switch to Evidence-Based Alternatives

You should discontinue mirtazapine immediately due to intolerable next-day effects and lack of efficacy for your insomnia, and switch to an FDA-approved hypnotic with proven efficacy. Mirtazapine is causing significant adverse effects (drowsiness, dizziness, anxiety) that are impairing your quality of life, and the FDA label explicitly warns about these exact problems 1.

Why Mirtazapine Is Not Working for You

The FDA drug label clearly states that mirtazapine causes sleepiness and impaired performance, warning patients not to drive or operate machinery until they know how it affects them 1. Your experience of next-day drowsiness and dizziness is a recognized and common adverse effect 1. More concerning, the label explicitly advises avoiding benzodiazepines during mirtazapine treatment due to additive sedative effects 1, and warns about discontinuation syndrome if stopped abruptly 1.

Critically, mirtazapine is not FDA-approved for insomnia—it's an antidepressant being used off-label. While recent research shows it can improve sleep in some patients 2, 3, the studies also confirm that adverse events frequently lead to discontinuation (6 out of 30 patients stopped mirtazapine due to side effects in one trial) 2. The fact that it's not improving your sleep while causing significant daytime impairment means you're experiencing the harms without the benefits.

Evidence-Based Alternatives You Should Use

The American Academy of Sleep Medicine 2017 clinical practice guideline provides clear recommendations for chronic insomnia 4. Notably, trazodone (another sedating antidepressant like mirtazapine) is explicitly NOT recommended for insomnia treatment 4, which reinforces that sedating antidepressants are not first-line therapy.

First-Line Pharmacologic Options (in order of strength):

For sleep maintenance problems (staying asleep):

  • Eszopiclone 2-3 mg: Improves both sleep onset and maintenance 4
  • Zolpidem 10 mg: Effective for sleep onset and maintenance 4
  • Suvorexant 10-20 mg: Specifically recommended for sleep maintenance 4
  • Doxepin 3-6 mg: Targets sleep maintenance specifically 4

For sleep onset problems (falling asleep):

  • Zaleplon 10 mg or Ramelteon 8 mg 4

The American College of Physicians 2016 guideline confirms that eszopiclone, zolpidem, and suvorexant have the strongest evidence (low-to-moderate strength) for improving sleep outcomes, though effect sizes are small 5. Importantly, this guideline found insufficient evidence for antidepressants like mirtazapine 5.

How to Safely Discontinue Mirtazapine

Do not stop abruptly. The FDA label warns about discontinuation syndrome with symptoms including dizziness, anxiety, agitation, nausea, sweating, confusion, and sensory disturbances 1. Your healthcare provider should taper the dose gradually rather than stopping suddenly 1.

Common discontinuation symptoms to watch for include:

  • Electric shock sensations (paresthesia)
  • Increased anxiety and agitation
  • Dizziness and headache
  • Nausea
  • Abnormal dreams 1

Critical Caveats

  1. The evidence for all sleep medications is limited: Even the "recommended" agents have only low-to-moderate quality evidence and small effect sizes 5. Long-term efficacy beyond a few weeks is largely unknown 5.

  2. Observational studies suggest serious long-term risks: Hypnotic use is associated with increased risk of dementia, fractures, and major injury 5. The FDA warns about cognitive and behavioral changes, including driving impairment 5.

  3. Cognitive-behavioral therapy for insomnia (CBT-I) should be prioritized: Both major guidelines emphasize that CBT-I is the preferred initial treatment 5, 4. Pharmacotherapy should ideally be reserved for those who don't respond to behavioral interventions.

  4. Avoid combining sedatives: The FDA specifically warns against using benzodiazepines or alcohol with mirtazapine 1, and this caution extends to other sedative-hypnotics to avoid excessive sedation.

Your next step: Contact your prescriber to arrange a gradual taper off mirtazapine while simultaneously starting one of the evidence-based hypnotics listed above, preferably after attempting or alongside CBT-I if you haven't already tried it.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.